Salusinβ, but Not Salusin-α, Promotes human umbilical vein endothelial cell inflammation via the p38 MAPK/ JNK-NF-κB Pathway

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Zhou, Cheng Hua ^a   Pan, Jin ^a   Huang, He ^a   Zhu, Yangzi ^a   Zhang, Mingxing ^a   Liu, Lian ^a   Wu, Yuqing ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; SALUSIN ALPHA; SALUSIN BETA; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; AUTACOID; CCL2 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; SIGNAL PEPTIDE; TNF PROTEIN, HUMAN; TOR2A PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; MOLECULAR PATHOLOGY; MONOCYTE CHEMOATTRACTANT PROTEIN 1 GENE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR CELL ADHESION MOLECULE 1 GENE; VASCULITIS; WESTERN BLOTTING; CELL CULTURE; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; SECRETION (PROCESS);

CELLS, CULTURED; CHEMOKINE CCL2; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFLAMMATION MEDIATORS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-6; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE SIGNALING SYSTEM; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1; VASCULITIS;

EID: 84929158921     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107555     Document Type: Article

References (23)

1. Bonetti PO, Lerman LO, Lerman A (2003) Endothelial dysfunction: A marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 23: 168-175.
2. Ross R (1999) Atherosclerosis-An inflammatory disease. N Engl J Med 340: 115-126.
3. Hansson GK (2009) Inflammatory mechanisms in atherosclerosis. J Thromb Haemost 7 Suppl 1: 328-331.
4. Bui QT, Prempeh M, Wilensky RL (2009) Atherosclerotic plaque development. Int J Biochem Cell Biol 41: 2109-2113.
5. Shichiri M, Ishimaru S, Ota T, Nishikawa T, Isogai T, et al. (2003) Salusins: newly identified bioactive peptides with hemodynamic and mitogenic activities. Nat Med 9: 1166-1172.
6. Watanabe T, Nishio K, Kanome T, Matsuyama TA, Koba S, et al. (2008) Impact of salusin-Alpha and-beta on human macrophage foam cell formation and coronary atherosclerosis. Circulation 117: 638-648.
7. Watanabe T, Suguro T, Sato K, Koyama T, Nagashima M, et al. (2008) Serum salusin-Alpha levels are decreased and correlated negatively with carotid atherosclerosis in essential hypertensive patients. Hypertens Res 31: 463-468.
8. Nagashima M, Watanabe T, Shiraishi Y, Morita R, Terasaki M, et al. (2010) Chronic infusion of salusin-A and-b exerts opposite effects on atherosclerotic lesion development in apolipoprotein E-deficient mice. Atherosclerosis 212: 70-77.
9. Zhou CH, Liu LL, Wu YQ, Song Z, Xing SH (2012) Enhanced expression of salusin-b contributes to progression of atherosclerosis in LDL receptor deficient mice. Can J Physiol Pharmacol 90: 463-471.
10. Zhou CH, Liu L, Liu L, Zhang MX, Guo H, et al. (2014) Salusin-b Not Salusina Promotes Vascular Inflammation in ApoE-Deficient Mice via the I-κBa/NFκB Pathway. PLoS One 9: e91468
11. Koya T, Miyazaki T, Watanabe T, Shichiri M, Atsumi T, et al. (2012) Salusin-b accelerates inflammatory responses in vascular endothelial cells via NF-κB signaling in LDL receptor-deficient mice in vivo and HUVECs in vitro. Am J Physiol Heart Circ Physiol 303: H96-105
12. Kumar A, Kingdon E, Norman J (2005) The isoprostane 8-iso-PGF2alpha suppresses monocyte adhesion to human microvascular endothelial cells via two independent mechanisms. FASEB J 19: 443-445.
13. Shi X, Siggins RW, Stanford WL, Melvan JN, Basson MD, et al. (2013) Toll-like receptor 4/stem cell antigen 1 signaling promotes hematopoietic precursor cell commitment to granulocyte development during the granulopoietic response to Escherichia coli bacteremia. Infect Immun 81: 2197-2205.
14. Reuther-Madrid JY, Kashatus D, Chen S, Li X, Westwick J, et al. (2002) The p65/RelA subunit of NF-kappa;B suppresses the sustained, antiapoptotic activity of Jun kinase induced by tumor necrosis factor. Mol Cell Biol 22: 8175-8183.
15. Linton MF, Fazio S (2003) Macrophages, inflammation, and atherosclerosis. Int J Obes Relat Metab Disord 27 Suppl 3: S35-40.
16. Galkina E, Ley K (2007) Leukocyte influx in atherosclerosis. Curr Drug Targets 8: 1239-1248.
17. Doran AC, Meller N, McNamara CA (2008) Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol 28: 812-819.
18. Libby P, Ridker PM, Maseri A (2002) Inflammation and atherosclerosis. Circulation 105: 1135-1143.
19. Missiou A, Köstlin N, Varo N, Rudolf P, Aichele P, et al. (2010) Tumor necrosis factor receptor-Associated factor 1 (TRAF1) deficiency attenuates atherosclerosis in mice by impairing monocyte recruitment to the vessel wall. Circulation 121: 2033-2044.
20. Collins T, Cybulsky MI (2001) NF-kappa;B: pivotal mediator or innocent bystander in atherogenesis? J Clin Invest 107: 255-264.
21. Olejarz W, Bryk D, Zapolska-Downar D, Malecki M, Stachurska A, et al. (2014) Mycophenolic acid attenuates the tumour necrosis factor-A-mediated proin-flammatory response in endothelial cells by blocking the MAPK/NF-κB and ROS pathways. Eur J Clin Invest 44: 54-64.
22. Lin ML, Lu YC, Chung JG, Wang SG, Lin HT, et al. (2010) Down-regulation of MMP-2 through the p38 MAPK-NF-kappa;B-dependent pathway by aloeemodin leads to inhibition of nasopharyngeal carcinoma cell invasion. Mol Carcinog 49: 783-797.
23. Ghosh J, Das J, Manna P, Sil PC (2009) Taurine prevents arsenic-induced cardiac oxidative stress and apoptotic damage: role of NF-kappa; B, p38 and JNK MAPK pathway. Toxicol Appl Pharmacol 240: 73-87.